Cost-effectiveness of adding cardiac resynchronization therapy to an implantable cardioverter-defibrillator among patients with mild heart failure

CY Woo, EJ Strandberg, MD Schmiegelow… - Annals of internal …, 2015 - acpjournals.org
Background: Cardiac resynchronization therapy (CRT) reduces mortality and heart failure
hospitalizations in patients with mild heart failure. Objective: To estimate the cost …

The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system …

M Landolina, G Morani, A Curnis, A Vado… - EP …, 2017 - academic.oup.com
Aims Patients receiving cardiac resynchronization therapy defibrillators (CRT-Ds) are likely
to undergo one or more device replacements, mainly for battery depletion. We assessed the …

Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial

AM Feldman, G De Lissovoy, MR Bristow… - Journal of the American …, 2005 - jacc.org
Objectives: The analysis goal was to estimate incremental cost-effectiveness ratios (ICERs)
for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure …

[HTML][HTML] ENDURALIFE-powered cardiac resynchronisation therapy defibrillator devices for treating heart failure: a NICE Medical Technology Guidance

JM Evans, A Cleves, H Morgan, L Millar… - … Health Economics and …, 2018 - Springer
ENDURALIFE™-powered cardiac resynchronisation therapy defibrillator (CRT-D) devices
were the subject of an evaluation by the National Institute for Health and Care Excellence …

Cardiac resynchronization therapy (CRT) in heart failure—a model to assess the economic value of this new medical technology

K Banz, Eucomed CRT Steering Committee - Value in Health, 2005 - Wiley Online Library
Objectives: This article describes the framework of a comprehensive European model
developed to assess clinical and economic outcomes of cardiac resynchronization therapy …

Modeling defibrillation benefit for survival among cardiac resynchronization therapy defibrillator recipients

KC Bilchick, Y Wang, JP Curtis, A Cheng… - American heart …, 2020 - Elsevier
Background Patients with heart failure having a low expected probability of arrhythmic death
may not benefit from implantable cardioverter defibrillators (ICDs). Objective The objective …

SIMULATED COST SAVINGS ASSOCIATED WITH CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) GENERATOR REPLACEMENT: A …

JL Williams, R Sato, C Jacobsen - Journal of the American College of …, 2024 - jacc.org
Background Battery depletion of cardiac resynchronization therapy-defibrillators (CRT-D)
poses a clinical and economic burden; extended service life may reduce the cost of …

Economic impact of cardiac resynchronization therapy in patients with heart failure. Available evidence and evaluation of the CRT-Eucomed model for analysis of cost …

G Fattore, M Landolina, L Bontempi… - Italian heart journal …, 2005 - europepmc.org
Several clinical trials show that cardiac resynchronization therapy (CRT) in patients with
moderate-severe heart failure increases survival, improves quality of life and reduces …

[HTML][HTML] Return on investment in implantable devices: cardiac resynchronization therapy in mildly symptomatic heart failure

BA Steinberg, RJ Mentz - JACC: Heart Failure, 2017 - jacc.org
The development of implantable cardiac devices for patients with heart failure has
significantly improved clinical outcomes. Clinical trials of implantable cardioverter …

Cardiac resynchronization therapy defibrillator at the end of battery life: In an era of economic uncertainty, do super-responders provide an opportunity for resource …

S Barra, S Agarwal - International …, 2015 - internationaljournalofcardiology.com
The decision to implant a cardiac resynchronization therapy defibrillator (CRT-D) vs. cardiac
resynchronization therapy pacemaker (CRT-P) is not always straightforward and should take …